These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11794810)

  • 1. Release kinetics of acyclovir from a suspension of acyclovir incorporated in a cubic phase delivery system.
    Helledi LS; Schubert L
    Drug Dev Ind Pharm; 2001 Nov; 27(10):1073-81. PubMed ID: 11794810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin ocular delivery systems based on glycerol monooleate reversed hexagonal and reversed cubic liquid crystalline phases.
    Milak S; Chemelli A; Glatter O; Zimmer A
    Eur J Pharm Biopharm; 2019 Jun; 139():279-290. PubMed ID: 31002864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the link between self-assembled mesophase structure and drug release.
    Phan S; Fong WK; Kirby N; Hanley T; Boyd BJ
    Int J Pharm; 2011 Dec; 421(1):176-82. PubMed ID: 21963475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and physicochemical characterization of acyclovir cocrystals with improved dissolution properties.
    Bruni G; Maietta M; Maggi L; Mustarelli P; Ferrara C; Berbenni V; Milanese C; Girella A; Marini A
    J Pharm Sci; 2013 Nov; 102(11):4079-86. PubMed ID: 24030886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of lipid-based drug delivery systems for enhancing solubility of highly selective antiviral agent acyclovir.
    Kazi M; Al-Amri KA; Alanazi FK
    Pharm Dev Technol; 2017 May; 22(3):312-321. PubMed ID: 26458371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Floating properties and release characteristics of hollow microspheres of acyclovir.
    Junyaprasert VB; Pornsuwannapha S
    Drug Deliv; 2008 Jun; 15(5):331-41. PubMed ID: 18763164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir.
    Masuda T; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K
    Int J Pharm; 2012 Jan; 422(1-2):160-9. PubMed ID: 22079714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release polymeric ocular delivery of acyclovir.
    Deshpande PB; Dandagi P; Udupa N; Gopal SV; Jain SS; Vasanth SG
    Pharm Dev Technol; 2010; 15(4):369-78. PubMed ID: 19772377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semisolid self-microemulsifying drug delivery systems (SMEDDSs): Effects on pharmacokinetics of acyclovir in rats.
    Djekic L; Janković J; Rašković A; Primorac M
    Eur J Pharm Sci; 2018 Aug; 121():287-292. PubMed ID: 29883728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glyceryl monooleate-based otic delivery system of ofloxacin: release profile and bactericidal activity.
    Adwan S; Abu-Dahab R; Al-Bakri AG; Sallam A
    Pharm Dev Technol; 2015 May; 20(3):361-6. PubMed ID: 24392877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swelling of and drug release from monoglyceride-based drug delivery systems.
    Chang CM; Bodmeier R
    J Pharm Sci; 1997 Jun; 86(6):747-52. PubMed ID: 9188059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility studies of acyclovir and lactose in physical mixtures and commercial tablets.
    Monajjemzadeh F; Hassanzadeh D; Valizadeh H; Siahi-Shadbad MR; Mojarrad JS; Robertson TA; Roberts MS
    Eur J Pharm Biopharm; 2009 Nov; 73(3):404-13. PubMed ID: 19631740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cubic phase gels as drug delivery systems.
    Shah JC; Sadhale Y; Chilukuri DM
    Adv Drug Deliv Rev; 2001 Apr; 47(2-3):229-50. PubMed ID: 11311994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro peptide release from liquid crystalline buccal delivery systems.
    Lee J; Kellaway IW
    Int J Pharm; 2000 Feb; 195(1-2):29-33. PubMed ID: 10675679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic characterization of swelling of liquid crystalline phases of glyceryl monooleate.
    Lee J; Choi SU; Yoon MK; Choi YW
    Arch Pharm Res; 2003 Oct; 26(10):880-5. PubMed ID: 14609139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual sustained release delivery system for multiple route therapy of an antiviral drug.
    Ramyadevi D; Sandhya P
    Drug Deliv; 2014 Jun; 21(4):276-92. PubMed ID: 24134619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of lamellar-to-cubic and intercubic phase transitions of pure and cytochrome c containing monoolein dispersions monitored by time-resolved small-angle X-ray diffraction.
    Kraineva J; Narayanan RA; Kondrashkina E; Thiyagarajan P; Winter R
    Langmuir; 2005 Apr; 21(8):3559-71. PubMed ID: 15807602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocrystals of acyclovir with promising physicochemical properties.
    Sarkar A; Rohani S
    J Pharm Sci; 2015 Jan; 104(1):98-105. PubMed ID: 25407552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
    Desai KG; Mallery SR; Schwendeman SP
    Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cubic phases for studies of drug partition into lipid bilayers.
    Engström S; Nordén TP; Nyquist H
    Eur J Pharm Sci; 1999 Aug; 8(4):243-54. PubMed ID: 10425374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.